Chelsea are reportedly interested in signing 29-year-old French international Mike Maignan from AC Milan this summer.
According to an update by Ben Jacobs, Chelsea have been handed a boost in their pursuit of Mike Maignan. The French international is reportedly pushing for a move to Chelsea, and it remains to be seen whether the two clubs can finalise an agreement.
The Frenchman is likely to cost around £20-25 million. Maignan is entering the final year of his contract, and AC Milan will be under pressure to sell him. They cannot afford to lose a player of his quality on a free transfer. It will be interesting to see how the situation develops.
Maignan would be a superb addition
Goalkeeper Robert Sanchez has been criticised for his mediocre performances, and Chelsea will be looking to replace him in the coming weeks. Mike Maignan would prove to be a huge upgrade on the Spanish goalkeeper. The French international is regarded as one of the finest goalkeeper in Europe right now, and he has the ability to compete at the highest level. He will help Chelsea improve next season.
The Blues have secured a return to the UEFA Champions League, and they will be hoping to fight for major trophies. They must look to address the weaknesses in their signing. A goalkeeper will be one of their priorities.
The AC Milan goalkeeper is not only a quality player, but he also has extensive experience playing for a big club. The Frenchman knows what it takes to succeed at a club like Chelsea, and he could be the ideal acquisition. Furthermore, his contract situation means that he could be signed for a reasonable amount of money. It remains to be seen whether Chelsea can finalise an agreement with the Italian club quickly.
AC Milan will not want to lose a player of his quality anytime soon, but they are powerless to stop him from leaving because of his contract situation. This summer is the last opportunity for them to recoup a substantial amount of money for the player. They cannot afford to lose a player of his ability on a free transfer.